Drug General Information
Drug ID	D0B9RI
Former ID	DNC013874
Drug Name	3-Benzyl-5-methoxychromen-2-one
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[530009]
Structure		Download 2D MOL 3D MOL
Formula	C17H14O3
Canonical SMILES	COC1=CC=CC2=C1C=C(C(=O)O2)CC3=CC=CC=C3
InChI	1S/C17H14O3/c1-19-15-8-5-9-16-14(15)11-13(17(18)20-16)10-12-6-3-2-4-7-12/h2-9,11H,10H2,1H3
InChIKey	XJSXZFXFKVCTQS-UHFFFAOYSA-N
PubChem Compound ID	16067269
Target and Pathway
Target(s)	Cannabinoid receptor 1	Target Info	Inhibitor	[530009]
KEGG Pathway	Rap1 signaling pathway
	Neuroactive ligand-receptor interaction
	Retrograde endocannabinoid signaling
PANTHER Pathway	Endogenous cannabinoid signaling
Pathway Interaction Database	N-cadherin signaling events
Reactome	Class A/1 (Rhodopsin-like receptors)
	G alpha (i) signalling events
WikiPathways	GPCRs, Class A Rhodopsin-like
	Small Ligand GPCRs
	BDNF signaling pathway
	GPCR ligand binding
	GPCR downstream signaling
	GPCRs, Other
References
Ref 530009	Bioorg Med Chem. 2009 Apr 1;17(7):2842-51. Epub 2009 Feb 21.Synthesis and pharmacological evaluation of coumarin derivatives as cannabinoid receptor antagonists and inverse agonists.
Ref 530009	Bioorg Med Chem. 2009 Apr 1;17(7):2842-51. Epub 2009 Feb 21.Synthesis and pharmacological evaluation of coumarin derivatives as cannabinoid receptor antagonists and inverse agonists.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.